comparision of two drugs used for normalizing low blood pressure in neonatal shock
Phase 2
- Conditions
- Health Condition 1: P299- Cardiovascular disorder originating in the perinatal period, unspecified
- Registration Number
- CTRI/2024/03/063900
- Lead Sponsor
- on funded
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Infants more than or equal to 34 weeks gestational age and more than or equal to 72 hours of life upto 3 months of age with fluid refractory shock will be enrolled in the study after taking informed consent from one of the parents.
Exclusion Criteria
1 Potentially lethal congenital malformations
2 Obvious blood loss
3 Post cardiac arrest shock.
4 Clinically suspected or echo proven congenital heart disease
5 Moderate to severe hypoxic ischaemic encephalopathy
6 Vasopressor drugs started prior to enrolment
7 Fluid responsive shock
8 Decline to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method